☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Haemophilia A
Roche Presents Results of Hemlibra Reinforcing the Long-Term Benefits for Hemophilia A at ASH 2020
December 7, 2020
Roche's Hemlibra Receives EU's Approval for Severe Haemophilia A without Factor VIII Inhibitors
March 14, 2019
Novo Nordisk Receives BLA Approval for Esperoct (turoctocog alfa pegol- N8-GP) for Patients with Haemophilia A
February 20, 2019
Roche's Hemlibra Receives the US FDA Approval for Haemophilia A Without Factor VIII Inhibitors
October 5, 2018
Bayer's BAY94-9027 Receives CHMP Approval for the Treatment of Haemophilia A aged ≥12yrs.
September 24, 2018
Roche's Hemlibra P-III Positive results for Haemophilia A without factor VIII being published in NEJM
August 30, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.